quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 11, 2026

Want to Own SpaceX Stock Before Its Blockbuster IPO? Here Are 3 Ways Investors Can Buy Right Now.

View original at nasdaq.com
“In 2026, SpaceX was valued at $1.25 trillion when it merged with xAI, meaning Alphabet's stake is now worth over $100 billion.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Wall Street expects Alphabet's earnings to increase at 15% annually over the next three years

    60% confidence

  • Ark Venture Fund seeks to democratize venture capital, offering all investors access to what we believe are the most innovative companies

    60% confidence

  • The current valuation of 30 times earnings looks reasonable for Alphabet

    60% confidence

  • Elon Musk hopes to raise $75 billion in the IPO, more than double the current record

    60% confidence

  • SpaceX is seeking a $1.75 trillion valuation in its IPO

    60% confidence

  • Baron Partners Fund seeks capital appreciation through investments in growth companies of any size with significant long-term potential

    60% confidence

Data points we hold from this source

SpaceX · market cap1250000000000.0 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Want to Own SpaceX Stock Before Its Blockbuster IPO? Here Are 3 Ways Investors Can Buy Right Now. — Source | Via News | pt.VIA.NEWS